Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: A clinicopathologic and immunohistochemical study of 75 cases

American Journal of Surgical Pathology

Volumn 27, Issue 3, 2003, Pages 311-324

  Rossi, Giulio ^a   Cavazza, Alberto ^b   Sturm, Nathalie ^d   Migaldi, Mario ^a   Facciolongo, Nicola ^b   Longo, Lucia ^c   Maiorana, Antonio ^a   Brambilla, Elisabeth ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Hospital of Faenza   (Italy)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokeratins; Immunohistochemistry; Lung; Pleomorphic carcinoma; TTF 1

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG SARCOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOSARCOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0346667037     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200303000-00004     Document Type: Article

References (79)

1. Addis BJ, Corrin B. Pulmonary blastoma, carcinosarcoma, and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. J Pathol 1985;147:291-301.
2. Agoff NS, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;13:238-42.
3. Attanoos RL, Papagiannis A, Suttinont P, et al. Pulmonary giant cell carcinoma: pathologic entity or morphologic phenotype? Histopathology 1998;32:225-31.
4. Battifora H. Spindle-cell carcinoma: ultrastructural evidence of squamous origin and collagen production by the tumor cells. Cancer 1976;37:2275-82.
5. Bejarano PA, Baughman RP, Biddinger PW, et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 1996;9:445-52.
6. Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000;8: 189-94.
7. Berho M, Moran CA, Suster S. Malignant mixed epithelial/mesenchymal neoplasms of the lung. Semin Diagn Pathol 1995;12:123-39.
8. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumors. Eur Respir J 2001;18: 1059-68.
9. Cagle PT, Alpert LC, Carmona PA. Peripheral biphasic adenocarcinoma of the lung: light microscopic and immunohistochemical findings. Hum Pathol 1992;23:197-200.
10. Chang YL, Lee YC, Shih JY, et al. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary nonsmall cell carcinoma. Lung Cancer 2001;34:91-7.
11. Chieng DC, Cangiarella JF, Zakowski MF, et al. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer (Cytopathol) 2001;93:330-6.
12. Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
13. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-39.
14. Colby TV, Koss M, Travis WD. Tumors of the lower respiratory tract. In: Atlas of Tumor Pathology, 3rd series, fascicle 13. Washington, DC: Armed Forces Institute of Pathology, 1994.
15. Colby TV. Malignancies in the lung and pleura mimicking benign processes. Semin Diagn Pathol 1995;12:30-44.
16. Dacic S, Finkelstein SD, Sasotomi E, et al. Molecular phatogenesis of pulmonary carcinosarcoma as determined by microdissectionbased allelotyping. Am J Surg Pathol 2002;26:510-6.
17. Di Loreto C, Di Lauro V, Puglisi F, et al. Immunohistochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 1997;50:30-2.
18. Essary LR, Vargas SO, Fletcher CDM. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer 2002;94:459-69.
19. Fishback NF, Travis WD, Moran CA, et al. Pleomorphic (spindle/giant cell) carcinoma of the lung: a clinicopathologic correlation of 78 cases. Cancer 1994;73:2936-45.
20. Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999;12:5-8.
21. Ginsberg SS, Buzaid AC, Stern H, et al. Giant cell carcinoma of the lung. Cancer 1992;70:606-10.
22. Guarino M, Tricomi P, Giordano F, et al. Sarcomatoid carcinomas: pathologic and histopathogenetic considerations. Pathology 1996; 28:298-305.
23. Guccion JG, Rosen SH. Bronchopulmonary leiomyosarcomas and fibrosarcomas: a study of 32 cases and review of the literature. Cancer 1972;30:835-47.
24. Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001; 116:483-8.
25. Hiroshima K, Ishibashi M, Ohwada H, et al. A case of adenocarcinoma of the lung with a spindle cell component. Acta Pathol Jpn 1992;42:841-6.
26. Hisaoka M, Hashimoto H, Iwamasa T, et al. Primary synovial sarcoma of the lung: report of two cases confirmed by molecular detection of SYT-SSX fusion gene trancript. Histopathology 1999; 34:205-10.
27. Holst VA, Finkelstein S, Colby TV, et al. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol 1997;21:801-11.
28. Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996;15:49-53.
29. Humphrey PA, Scroggs MW, Roggli VL, et al. Pulmonary carcinoma with sarcomatoid element. Hum Pathol 1988;19:155-65.
30. Ikura Y, Inoue T, Tsukuda H, et al. Primary choriocarcinoma and human chorionic gonadotrophin-producing giant cell carcinoma of the lung: are they independent entities? Histopathology 2000;36: 17-25.
31. Ishida T, Tateishi M, Kaneko S, et al. Carcinosarcoma and spindle cell carcinoma of the lung: clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg 1990;100:844-52.
32. Kaplan MA, Goodman MD, Satish J, et al. Primary pulmonary sarcoma with morphologic features of monophasic synovial sarcoma and chromosome translocation t(X;18). Am J Clin Pathol 1996;105:195-9.
33. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000;36:415-20.
34. Keel SB, Bacha E, Mark EJ, et al. Primary pulmonary sarcomas: a clinicopathologic study of 26 cases. Mod Pathol 1999;12:1124-31.
35. Khoor A, Whitsett JA, Stahlman MT, et al. Utility of surfactant protein B precursor and TTF-1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999;30: 695-700.
36. Koss MN, Hochholzer L, O'Leary T. Pulmonary blastomas. Cancer 1991;67:2368-81.
37. Koss MN, Hochholzer L, Frommelt AR. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999;23:1514-26.
38. Krompecher E. Der drusernartige oberflachen-epitheliakrebscarcinom epitheliale adenoides. Beitr Pathol 1900;28:1-41.
39. Leroy X, Copin MC, Boman F, et al. Les cytokératines 7 et 20: aide au typage des tumeurs. Ann Pathol 1998;18:103-9.
40. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102:764-7.
41. Matsui K, Kitagawa M, Miwa A. Lung carcinoma with spindle cell components: sixteen cases examined by immunohistochemistry. Hum Pathol 1992;23:1289-97.
42. Matsui K, Kitagawa M. Spindle cell carcinoma of the lung: a clinicopathologic study of three cases. Cancer 1991:67:2361-7.
43. Miettinen M, Franssila KO. Variable expression of keratins and nearly uniform lack of thyroid transcription factor I in thyroid anaplastic carcinoma. Hum Pathol 2000;31:1139-45.
44. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-8.
45. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
46. Mountain CF. Revisions of the International System for staging lung cancer. Chest 1997;111:1710-7.
47. Nakajima M, Kasai T, Hashimoto H, et al. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 1999; 86:608-16.
48. Nappi O, Glasner SD, Swanson PE, et al. Biphasic and monophasic sarcomatoid carcinomas of the lung: a reappraisal of 'carcinosarcomas' and 'spindle cell carcinomas.' Am J Clin Pathol 1994;102: 331-40.
49. Nappi O, Wick MR. Sarcomatoid neoplasms of the respiratory tract. Semin Diagn Pathol 1993;10:137-47.
50. Nascimento AG, Unni KK. Sarcomas of the lung. Mayo Clin Proc 1982;6:119-23.
51. Nicholson AG, McCormick CJ, Shimosato Y, et al. The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumors. Histopathology 1995;27:57-60.
52. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000;7:123-7.
53. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000;24:1217-23.
54. Pelosi G, Fraggetta F, Pasini F, et al. Pleomorphic carcinomas (PCs) of the lung represent a spectrum of nonsmall cell cancer (NSCLC) with divergent epithelial and sarcomatous differentiation [Abstract]. Mod Pathol 2002;15:326.
55. Rainosek DE, Ro JY, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a case with atypical carcinoid and rhabdomyosarcomatous components. Am J Clin Pathol 1994;102:360-4.
56. Ramaekers F, van Niekerk C, Poels L, et al. Use of monoclonal antibodies to keratin 7 in the differential disgnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
57. Reis-Filho JS, Carrilho C, Valenti C, et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Pathol Res Pract 2000;196:835-40.
58. Ritter JH, Mills SE, Nappi O, et al. Angiosarcoma-like neoplasms of epithelial organs: true endothelial tumors or variants of carcinoma? Semin Diagn Pathol 1995;12:270-82.
59. Ro JY, Chen JL, Lee JS. et al. Sarcomatoid carcinoma of the lung: immunohistochemical and ultrastructural studies of 14 cases. Cancer 1992;69:376-86.
60. Roggli VI, Voller RT, Greenberg SD, et al. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985;16:569-79.
61. Saphir O, Vass A. Carcinosarcoma. Am J Cancer 1938;33:331-59.
62. Sheppard MN. Specific markers for pulmonary tumors. Histopathology 2000;36:273-6.
63. Sobin LH, Wittekind CH, eds. UICC TNM Classification of Malignant Tumors, 5th ed. New York. John Wiley and Sons, 1997.
64. Stackhouse EM, Harrison, EG Jr, Ellis FH Jr. Primary mixed malignancies of lung: carcinosarcoma and blastoma. J Thorac Cardiovasc Surg 1969;57:385-99.
65. Sturm N, Rossi G, Lantuejoul S, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002; 33:175-82.
66. Sturm N, Lantuejoul S, Laverriere MH, et al. Thyroid transcription factor-1 (TTF-1) and cytokeratin 1, 5, 10, 14 (34βE12) expression in basaloid and large cell neuronedocrine carcinomas of the lung. Hum Pathol 2001;32:918-25.
67. Suster S, Huszar M, Herczeg E. Spindle-cell carcinoma of the lung: immunocytochemical and ultrastructural study of a case. Histopathology 1987;11:871-8.
68. Suster S. Primary sarcomas of the lung. Semin Diagn Pathol 1995; 12:140-57.
69. Tanoue LT, Ponn RB. Therapy for stage I and stage II nonsmall cell lung cancer. Clin Chest Med 2002;23:173-90.
70. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas): evidence for a divergent histogenesis. Am J Surg Pathol 1996;20:277-85.
71. Travis WD. Pathology of lung cancer. Clin Chest Med 2002;23: 65-81.
72. Travis WD, Colby TV, Corrin B, et al. In collaboration with Sobin LH and Pathologists from 14 countries. World Health Organization International Histological Classification of Tumors. Histological Typing of Lung and Pleural Tumors, 3rd ed. Berlin: Springer-Verlag, 1999.
73. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75: 191-202.
74. Tsubota YT, Kagawaguchi T, Hoso T, et al. A combined small cell carcinoma and spindle cell carcinoma of the lung: report of a unique case with immunohistochemical and ultrastructural studies. Am J Surg Pathol 1992;16:1108-15.
75. Wick MR, Ritter JH, Humphrey PA. Sarcomatoid carcinomas of the lung: a clinicopathologic review. Am J Clin Pathol 1997;108: 40-53.
76. Wick MR, Ritter JH, Nappi O. Inflammatory sarcomatoid carcinoma of the lung: report of three cases and clinicopathologic comparison with inflammatory pseudotumors in adult patients. Hum Pathol 1995;26:1014-21.
77. Wick MR, Swanson PE. Carcinosarcomas: current perspectives and an historical review of nosologic concepts. Semin Diagn Pathol 1993;10:118-27.
78. Xu X, Yin H, Meng K, et al. Pathological study of the pleomorphic carcinoma of the lung. Zhonghua Bing Li Xue Za Zhi 2000;29: 424-7.
79. Zeren EH, Moran CA, Suster S, et al. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathologic, immunohistochemical, and ultrastructural study of 25 cases. Hum Pathol 1995;26:474-80.